Tivozanib kidney cancer drug. Close-up of a tub containing capsules of the kidney cancer drug tivozanib, marketed under the name Fotivda. Tivozanib is


Tivozanib kidney cancer drug. Close-up of a tub containing capsules of the kidney cancer drug tivozanib, marketed under the name Fotivda. Tivozanib is an oral VEGF receptor tyrosine kinase inhibitor used for the treatment of first line (treatment naive) patients with renal cell carcinoma.


Size: 5173px × 3449px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, abnormal, background, biochemical, biochemistry, black, cancer, capsule, capsules, carcinoma, cell, chemical, chemistry, close-, condition, cut, cut-, cut-outs, cutout, cutouts, detail, disorder, drug, drugs, fotivda, healthcare, inhibitor, kidney, kinase, line, medical, medicine, nephrology, oncological, oncology, oral, outs, packaged, packaging, pharmaceutic, pharmaceutical, pharmacological, pharmacology, prescription, receptor, renal, tivozanib, treatment, tub, tyrosine, unhealthy, vegf